In search of mixed anxiety-depressive disorder: a primary care study

Depression and Anxiety
Adrienne J Means-ChristensenM B Stein

Abstract

The diagnosis of mixed anxiety-depressive disorder, as proposed in DSM-IV, is intended to be useful in settings such as primary care, where low-level anxiety and depressive symptoms may cause clinically significant impairment but are undiagnosable using current criteria. Evidence of the prevalence of this diagnosis is, however, lacking, particularly since the publication of the proposed diagnostic criteria in DSM-IV. Our study examined symptoms of anxiety and depression in 65 primary care patients screened for anxiety and depression while visiting their doctor. Results indicated that of the 37 patients without a diagnosable anxiety or depressive disorder, none had symptoms of depression and anxiety accompanied by interference that the patient deemed significant and attributable to his or her symptoms. These data dispute the need for a mixed anxiety-depression category (beyond mood and anxiety syndromes currently in DSM-IV) in future editions of the DSM.

References

Nov 1, 1992·International Journal of Cell Cloning·A UrabeF Takaku
Aug 1, 1991·Journal of Abnormal Psychology·W Katon, P P Roy-Byrne
Mar 1, 1989·Journal of Affective Disorders·W HillerM von Bose
May 17, 1995·Journal of Affective Disorders·M B SteinM Terepa
Sep 1, 1994·Journal of General Internal Medicine·P Roy-ByrneM Liebowitz
Aug 1, 1994·The American Journal of Psychiatry·R E ZinbargJ Richards
Jun 14, 2002·General Hospital Psychiatry·Michelle G CraskeGreer Sullivan
Dec 6, 2003·International Journal of Methods in Psychiatric Research·Adrienne Means-ChristensenMurray B Stein
Mar 17, 2004·Journal of Affective Disorders·Katrin BarkowWolfgang Maier
Mar 9, 2005·Archives of General Psychiatry·Peter P Roy-ByrneCathy D Sherbourne
Apr 5, 2005·The Journal of Nervous and Mental Disease·Risa B WeisbergMartin B Keller

❮ Previous
Next ❯

Citations

Mar 20, 2013·CNS Spectrums·Dawn F IonescuCarlos A Zarate
Jun 2, 2012·The Journal of Nervous and Mental Disease·Neeltje M BatelaanPim Cuijpers
Mar 1, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jude U Ohaeri, Abdel W Awadalla
Jan 10, 2004·American Journal of Public Health·Bonnie DuranJoel Yager
Jul 11, 2008·Primary Care Companion to the Journal of Clinical Psychiatry·Boadie W Dunlop, Paula G Davis
Nov 1, 2010·International Journal of Psychiatry in Clinical Practice·Krzysztof MałyszczakAndrzej Kiejna
Feb 20, 2016·International Journal of Mental Health Nursing·Daniel López LópezRicardo Becerro de Bengoa Vallejo
Jul 19, 2015·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Marshall GoldChristine Miaskowski
Feb 5, 2010·Psychiatry Research·Matteo BalestrieriCesario Bellantuono
Nov 28, 2013·Depression and Anxiety·David P Goldberg
Jan 26, 2010·Depression and Anxiety·Kate B Wolitzky-TaylorMichelle G Craske
Apr 6, 2018·Foot & Ankle International·Rachel ShakkedSteven M Raikin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.